Compagnie Lombard Odier SCmA Buys New Holdings in Agilent Technologies, Inc. $A

Compagnie Lombard Odier SCmA purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 8,500 shares of the medical research company’s stock, valued at approximately $1,157,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. AQR Capital Management LLC lifted its holdings in shares of Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after buying an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. grew its stake in Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after acquiring an additional 1,340,161 shares in the last quarter. Troy Asset Management Ltd increased its holdings in Agilent Technologies by 74.3% in the 2nd quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock valued at $282,967,000 after acquiring an additional 1,021,865 shares during the last quarter. Ilex Capital Partners UK LLP purchased a new stake in Agilent Technologies in the 2nd quarter worth $96,684,000. Finally, SG Americas Securities LLC lifted its stake in Agilent Technologies by 3,091.1% in the 4th quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company’s stock worth $109,974,000 after purchasing an additional 782,888 shares in the last quarter.

Agilent Technologies Trading Up 0.8%

A opened at $115.44 on Friday. The stock has a 50-day moving average of $121.67 and a 200 day moving average of $134.51. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27. The firm has a market cap of $32.62 billion, a P/E ratio of 25.48, a P/E/G ratio of 2.41 and a beta of 1.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be paid a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. Agilent Technologies’s payout ratio is currently 22.52%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on A shares. UBS Group cut their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Morgan Stanley decreased their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. The Goldman Sachs Group began coverage on Agilent Technologies in a report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price target for the company. Wells Fargo & Company reduced their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Finally, Barclays decreased their price objective on Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.